MARINUS PHARMACEUTICALS INC - COM (MRNS) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q1 2021

Type / Class
Equity / COM
Symbol
MRNS on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of MARINUS PHARMACEUTICALS INC - COM (MRNS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2021 Q1 0 $0 -$17,841,000 0
2020 Q4 1,462,388 $17,841,000 -$53,879,012 $12.20 2
2020 Q3 5,655,272 $72,671,000 -$401,029,562 $12.85 4
2020 Q2 90,970,556 $231,061,056 +$67,936,776 $2.54 92
2020 Q1 64,511,989 $130,953,889 +$17,013,055 $2.03 72
2019 Q4 56,080,885 $121,137,540 +$55,077,247 $2.16 75
2019 Q3 31,231,281 $48,093,608 -$18,733,149 $1.54 61
2019 Q2 33,785,472 $140,140,898 +$5,777,260 $4.15 74
2019 Q1 33,294,805 $139,080,519 +$1,016,648 $4.18 78
2018 Q4 34,302,537 $98,415,638 -$19,872,150 $2.87 87
2018 Q3 27,883,850 $278,777,860 +$21,813,158 $10.00 96
2018 Q2 21,442,872 $151,599,133 +$29,847,423 $7.07 70
2018 Q1 22,774,581 $86,973,000 -$37,965,595 $3.82 58
2017 Q4 25,785,438 $210,439,000 +$25,429,358 $8.16 65
2017 Q3 20,123,902 $118,160,000 +$80,577,525 $5.87 38
2017 Q2 7,496,847 $10,271,000 +$171,014 $1.37 21
2017 Q1 7,327,447 $12,970,000 +$4,638,615 $1.77 24
2016 Q4 4,931,632 $4,979,000 -$2,009,797 $1.01 22
2016 Q3 6,056,814 $11,024,000 -$3,254,832 $1.82 25
2016 Q2 8,896,332 $11,299,000 -$6,223,890 $1.27 25
2016 Q1 9,760,822 $52,514,000 -$2,839,280 $5.38 30
2015 Q4 9,983,454 $76,272,000 +$26,069,860 $7.64 37
2015 Q3 6,506,487 $54,259,000 +$1,632,202 $8.34 37
2015 Q2 6,310,311 $73,197,000 +$5,449,313 $11.60 26
2015 Q1 5,895,505 $52,844,000 +$357,607 $8.99 20
2014 Q4 5,842,896 $61,690,000 +$907,445 $10.55 14
2014 Q3 5,376,657 $34,786,000 +$34,786,000 $6.47 17